Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nucleosome autoantibodies.

Patrice Decker1

  • 1Institute for Cell Biology, Department of Immunology, University of Tübingen, Auf der Morgenstelle 15, D-72076 Tübingen, Germany. patrice.decker@uni-tuebingen.de

Clinica Chimica Acta; International Journal of Clinical Chemistry
|December 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of JAK-inhibition on pain and biphasic P2X7R expression on CD4<sup>+</sup> T cells in experimental arthritis.

Scientific reports·2026
Same author

Induction, Isolation, and Characterization of Human Neutrophil Extracellular Traps (NETs) to Be Used in Functional Assays.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Neutrophils Display Novel Partners of Cytosolic Proliferating Cell Nuclear Antigen Involved in Interferon Response in COVID-19 Patients.

Journal of innate immunity·2025
Same author

Neutrophil extracellular traps (NET): not only antimicrobial but also modulators of innate and adaptive immunities in inflammatory autoimmune diseases.

RMD open·2023
Same author

The exposome in rheumatoid arthritis.

Joint bone spine·2022
Same author

Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.

Frontiers in immunology·2021
Same journal

Comparing conventional correction formulas and machine learning-based prediction of ionized calcium.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Micro- and nanoplastics as emerging clinical analytes: analytical validation, interpretive uncertainty, and laboratory actionability in human specimens.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Performance of Free Light Chain reagents in the Dutch External Quality Assessment programme over the past 14 years.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

CRISPR-Cas12a-based liquid biopsy technology: challenges in large-scale clinical application.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Diagnostic biomarkers, prognostic signatures, and therapeutic resistance: shedding light on the dual role of autophagy in glioblastoma.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Artificial intelligence in diagnostic software: validation, safety, and lifecycle challenges in Europe.

Clinica chimica acta; international journal of clinical chemistry·2026
See all related articles

Nucleosomes, normally inside cells, can trigger immune responses when released externally. This review explores how nucleosomes become immunogenic, leading to autoantibodies in diseases like systemic lupus erythematosus (SLE).

Area of Science:

  • Molecular Biology
  • Immunology
  • Genetics

Background:

  • Nucleosomes are key protein-nucleic acid complexes for DNA packing and gene regulation within the cell nucleus.
  • Under specific conditions, nucleosomes can be released into the extracellular environment, becoming accessible to immune cells.
  • The precise reasons for nucleosome immunogenicity remain under investigation.

Purpose of the Study:

  • To review the mechanisms of nucleosome release and subsequent immune system activation.
  • To explore the development of anti-nucleosome autoantibodies (autoAb).
  • To discuss the role of nucleosomes in the pathogenesis of autoimmune diseases, particularly systemic lupus erythematosus (SLE).

Main Methods:

  • Literature review of existing research on nucleosome biology and autoimmunity.

Related Experiment Videos

  • Analysis of studies investigating nucleosome production and release.
  • Examination of data linking anti-nucleosome autoantibodies to disease pathology.

    • Main Results:

    • Nucleosomes can transition from intracellular to extracellular locations, engaging the immune system.
    • Certain conditions render nucleosomes immunogenic, prompting autoantibody production.
    • Anti-nucleosome autoantibodies are significant biomarkers in connective tissue diseases, especially SLE.

    Conclusions:

    • Nucleosome release and subsequent immune recognition are critical in developing anti-nucleosome autoimmunity.
    • Understanding these mechanisms provides insight into the pathogenesis of SLE and related disorders.
    • Further research is needed to fully elucidate the triggers and pathways of nucleosome-induced immune responses.